USP 795

INDUSTRY UPDATE: USP 795 & Quality Nonsterile Compounds Webinar

2022-09-27T15:25:52-05:00September 13th, 2022|Categories: Pharmacist Training, Pharmacy Technician, USP 795|Tags: , |

USP has proposed revisions to chapter <795> which creates minimum standards for compounding of nonsterile dosage forms for both human and animal patients. Attendees will learn about the changes from the current version of USP <795>, highlight key themes in the proposed changes, and prepare themselves to meet or exceed these new standards. In addition, attendees will learn how some the concepts coincide with the FDA’s Insanitary Conditions Guidance document and the role this currently plays in pharmacy practice.

Tuesday, October 11, 2022
12 Noon Eastern / 11:00 am Central / 10:00 am Mountain / 9:00 am Pacific

ACA & ACVP Members: FREE
Non-Members: $20

Learning Objectives:

  1. Define the changes in the proposed USP <795> compared to the current USP <795>
  2. Illustrate the role that personnel and appropriate facilities play in limiting potential contamination of nonsterile compounds.
  3. Analyze the key themes of the proposed USP <795> and how they coincide with the FDA’s Insanitary Conditions Guidance
  4. Plan to implement any changes needed for compliance and quality of nonsterile compounds.

This webinar does not offer CE.

Register below. After you register, you will be directed to Zoom to complete your sign up and receive your Zoom webinar links via email.

Loading…
USP795 Webinar Oct 2022

Matt Martin, PharmD, BCSCP, joined the PCCA Clinical Services team in September 2014 and now serves as Director of Clinical Services. He graduated from Morehead State University with a BS in Chemistry in 2002 and received his PharmD from the University of Kentucky College of Pharmacy in 2006. In 2020, Matt became board certified in Compounded Sterile Preparations through the Board of Pharmacy Specialties. Prior to joining the PCCA team, Matt worked in compounding pharmacy for more than eight years and has experience with both sterile and non-sterile preparations.

ACA’s Response to the Update on USP Compounding Standards

2019-09-25T14:45:00-05:00September 25th, 2019|Categories: News Release, USP 795, USP 797|

On September 23, 2019, ACA received notification that due to ongoing appeals, implementation of proposed changes to USP Chapters 795 and 797 will not occur on December 1, 2019. This is good news for compounding pharmacy: the scope of the revisions to USP Chapters 795 and 797 – and the impact that the current revisions as written would have on maintaining patients’ access to compounded medications and on the preservation of local, independent community pharmacies’ ability to continue to compound—were too great.

ACA is committed to providing compounding training that reflects the USP Chapter Standards. We are in the process of updating the curricula for our 2020 live and online courses to reflect the proposed changes as they are currently written. Once USP makes a decision to deny or remand the ongoing appeals to Chapters 795 and 797, and communicates a new implementation schedule, we will adjust our revisions and training updates accordingly on our website.

If you have any questions about ACA compounding training or the inclusion of USP Chapter Standards in our curricula, please contact us at training@acainfo.org. Click here to read the notice from USP.

Sincerely,

 

Susan Bartlemay, RPh, FACA, FAPhA
Executive Director | CEO
American College of Apothecaries

Go to Top